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Background:  The need for defibrillation testing with standard left pectoral implants and dual coil transvenous leads is controversial, as 
defibrillation thresholds (DFT) are low. However, the need for testing with right-sided implants is less well understood.
Methods:  We performed a retrospective case-control analysis of DFT’s in consecutive patients undergoing transvenous cardioverter-defibrillator 
implantation. All patients underwent a uniform, modified step-down DFT protocol, with an elevated DFT defined as greater than or equal to 25 J.
Results:  There were 28 patients receiving right-sided implants and 185 patients receiving left-sided implants. Patients receiving right vs left sided 
implants were similar with regards to age (61.8 ±12.3 vs 62.9 ± 11.9 years, p = 0.67), gender (71.4% vs 75.1% males, p = 0.67), left ventricular 
ejection fraction (32.2 ± 9.2% vs 31.6 ± 12.8%, p = 0.80), etiology of heart failure (ischemic in 50% vs 60%, p = 0.32), use of amiodarone (10.7% 
vs 11.4%, p = 0.92), and NYHA class (2.4 ± 0.7 vs 2.6 ± 0.7, p = 0.32). In right-sided implants, there was a trend towards higher absolute DFT and 
more than doubling of the prevalence of elevated DFT (Table).
Conclusions: An inadequate defibrillation safety margin is present in 14% of right-sided implants. Therefore, decisions regarding the need for 
testing of right-sided implants should not be extrapolated from results of trials of left sided implants. 
Right Left P value
DFT (J) 14.1 ± 8.3 11.8 ± 6.6 0.09
High DFT (>/= 25 J, %) 14.3 6.0 0.07
